Skip to main content
. 2017 Jan 10;65(4):1278–1292. doi: 10.1002/hep.28947

Figure 2.

Figure 2

Viral binding and replication in cholangiocytes treated with TRTRVSRLY as a function of rotavirus strain. Mouse cholangiocytes were pretreated with 1 mM synthetic peptide TRTRVSRLY followed by infection with RRV, TUCH, Ro1845, or GRV. (A) Viral binding revealed significant inhibition of binding only in strains that induce murine biliary atresia (RRV and GRV). DGEA and GHRP are positive and negative controls, respectively. (B) A significant reduction in viral yield in RRV and GRV was measured, with no decrease in replication for TUCH or Ro1845. *P < 0.05 versus serum‐free media.